Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis
G V Papatheodoridis Liver Transplantation and
Hepatobiliary Medicine, Royal Free Hospital, London, UK
Correspondence to: Dr A K Burrhoughs, Liver
Transplantation and Hepatobiliary Medicine, Royal Free Hospital, Pond
Street, Hampstead, London NW3 2QG, UK.
Accepted for publication 16 April 1998 Background Keywords:
liver transplantation;
inflammatory bowel disease;
ulcerative colitis;
primary sclerosing cholangitis;
immunosuppression
The course of inflammatory bowel
disease after liver transplantation has been reported as variable with
usually no change or improvement, but there may be an increased risk of early colorectal neoplasms. In many centres steroids are often withdrawn early after transplantation and this may affect inflammatory bowel disease activity.
AimsTo evaluate the course of inflammatory bowel
disease in primary sclerosing cholangitis transplant patients who were
treated without long term steroids.
MethodsBetween 1989 and 1996, there were 30 patients transplanted for primary sclerosing cholangitis who survived
more than 12 months. Ulcerative colitis was diagnosed in 18 (60%)
patients before transplantation; two had previous colectomy. All
patients underwent colonoscopy before and after transplantation and
were followed for 38 (12-92) months. All received cyclosporin or
tacrolimus with or without azathioprine as maintenance immunosuppression.
ResultsUlcerative colitis course after
transplantation compared with that up to five years before
transplantation was the same in eight (50%) and worse in eight (50%)
patients. It remained quiescent in eight and worsened in four of the 12 patients with pretransplant quiescent course, whereas it worsened in
all four patients with pretransplant active course (p=0.08). New onset ulcerative colitis developed in three (25%) of the 12 patients without
inflammatory bowel disease before transplantation. No colorectal cancer
has been diagnosed to date.
ConclusionsPreexisting ulcerative colitis often
has an aggressive course, while de novo ulcerative colitis may develop
in patients transplanted for primary sclerosing cholangitis and treated without long term steroids.
(GUT 1998;43:639-644)
© 1998 by Gut
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Article
- The colon and PSC: new liver, new danger?
- R W CHAPMAN
Gut 1998 43: 595-596.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
JAYARAM, H, SATSANGI, J, CHAPMAN, R W G
(2001). Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?. Gut
48: 430-434
[Full Text]
- Full Text
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
